इंद्र सहदान दाऊद

1. Pembrolizumab versus Ipilimumab in Advanced Melanoma

   · 2015 · cited 5,102x

2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

   · 2021 · cited 4,135x

3. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

   · 2013 · cited 2,878x

4. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

   · 2012 · cited 2,360x

5. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

   · 2020 · cited 2,161x

via Crossref · CC0

via Wikidata sitelinks · CC0